| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | 0.17 | 0.4 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.4 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.4 |